Related Experiment Video
Updated: May 20, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Risk factor reduction in progression of angiographic coronary artery disease
Hoang M Lai1, Wilbert S Aronow, Anthony D Mercando
1Department of Medicine, Cardiology Division, New York Medical College, Valhalla, New York, USA.
Insights
Progressive coronary artery disease (CAD) was observed in 59% of outpatients. Higher mean arterial pressure was linked to CAD progression, suggesting blood pressure and LDL-C control are crucial for managing coronary artery disease.
Area of Science:
- Cardiology
- Vascular Medicine
- Preventive Cardiology
Background:
- Coronary artery disease (CAD) is a leading cause of mortality worldwide.
- Understanding factors influencing CAD progression is vital for patient management.
- Differentiating progressive from nonprogressive CAD in outpatients requires further investigation.
Purpose of the Study:
- To compare characteristics of outpatients with progressive versus nonprogressive coronary artery disease (CAD).
- To identify clinical factors associated with CAD progression in an outpatient cardiology setting.
Main Methods:
- Retrospective chart review of outpatients with at least two coronary angiographies (≥ 1 year apart).
- Progressive CAD defined by new CAD in previously disease-free vessels or new obstruction in previously non-obstructive vessels.
- Analysis included coronary risk factors, comorbidities, cardiovascular events, medications, serum low-density lipoprotein cholesterol (LDL-C), and blood pressure.
Main Results:
- 183 outpatients (mean age 71) were analyzed with a mean follow-up of 11 years.
- 59% (108/183) exhibited progressive CAD over a mean of 58 months between angiographies.
- Progressive CAD was associated with significantly higher mean arterial pressure (97±13 vs. 92±12 mm Hg; p<0.05).
- Serum LDL-C was insignificantly higher in progressive CAD patients (94±40 vs. 81±34 mg/dl; p=0.09).
- Medication use (statins, beta-blockers, ACE inhibitors/ARBs, aspirin) did not differ significantly between groups.
Conclusions:
- Elevated mean arterial pressure is a significant factor in CAD progression among outpatients.
- While not statistically significant, higher LDL-C levels trended with disease progression.
- Optimizing blood pressure and LDL-C control, alongside medical therapy, may be key to slowing coronary artery disease progression.
Introduction:
To investigate differences between outpatients with progressive and nonprogressive coronary artery disease (CAD) measured by coronary angiography.
Material And Methods:
Chart reviews were performed in patients in an outpatient cardiology practice having ≥ 2 coronary angiographies ≥ 1 year apart. Progressive CAD was defined as 1) new non-obstructive or obstructive CAD in a previously disease-free vessel; or 2) new obstruction in a previously non-obstructive vessel. Coronary risk factors, comorbidities, cardiovascular events, medication use, serum low-density lipoprotein cholesterol (LDL-C), and blood pressure were used for analysis.
Results:
The study included 183 patients, mean age 71 years. Mean follow-up duration was 11 years. Mean follow-up between coronary angiographies was 58 months. Of 183 patients, 108 (59%) had progressive CAD, and 75 (41%) had nonprogressive CAD. The use of statins, β-blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and aspirin was not significantly different in patient with progressive CAD or nonprogressive CAD Mean arterial pressure was higher in patients with progressive CAD than in patients with nonprogressive CAD (97±13 mm Hg vs. 92±12 mm Hg) (p<0.05). Serum LDL-C was insignificantly higher in patients with progressive CAD (94±40 mg/dl) than in patients with nonprogressive CAD (81±34 mg/dl) (p=0.09).
Conclusions:
Our data suggest that in addition to using appropriate medical therapy, control of blood pressure and serum LDL-C level may reduce progression of CAD.
More Related Videos
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction
Coronary Artery Disease V: Interprofessional Care
Angina IV: Management
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

